Intervention Review

Sargramostim (GM-CSF) for induction of remission in Crohn's disease

  1. Lee Roth2,
  2. John K MacDonald3,
  3. John WD McDonald3,
  4. Nilesh Chande1,*

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 9 NOV 2011

Assessed as up-to-date: 19 APR 2011

DOI: 10.1002/14651858.CD008538.pub2


How to Cite

Roth L, MacDonald JK, McDonald JWD, Chande N. Sargramostim (GM-CSF) for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD008538. DOI: 10.1002/14651858.CD008538.pub2.

Author Information

  1. 1

    London Health Sciences Centre - Victoria Hospital, London, Ontario, Canada

  2. 2

    McMaster University, Faculty of Health Sciences, Hamilton, ON, Canada

  3. 3

    Robarts Research Institute, Robarts Clinical Trials, London, Ontario, Canada

*Nilesh Chande, London Health Sciences Centre - Victoria Hospital, Room E1-423A, 800 Commissioners Road East, London, Ontario, N6A 5W9, Canada. nchande2@uwo.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 9 NOV 2011

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.